当前位置：
X-MOL 学术
›
Blood Cancer J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia.
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-11-20 , DOI: 10.1038/s41408-024-01189-2 Xiaohui Suo,Xiaojun Ma,Fang Zheng,Dongmei Wang,Guanchen Bai,Liyun Zhao,Zhongjing Han,Xin Lv,Congcong Zhang,Ju Wang,Kangxin Tuo,Zhen Meng,Shan Liu,Sifeng Gao,Jilei Zhang,Zongjiu Jiao,Jiaojie Song,Ling Li,Xinxiao Lu,Linyu Yuan,Kaiqi Liu,Xingli Zhao,Yingchang Mi
中文翻译：
维奈托克联合三天多频地西他滨 （DEC3-VEN） 治疗不适合的老年或强化化疗的新诊断急性髓性白血病患者。
更新日期：2024-11-20
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-11-20 , DOI: 10.1038/s41408-024-01189-2 Xiaohui Suo,Xiaojun Ma,Fang Zheng,Dongmei Wang,Guanchen Bai,Liyun Zhao,Zhongjing Han,Xin Lv,Congcong Zhang,Ju Wang,Kangxin Tuo,Zhen Meng,Shan Liu,Sifeng Gao,Jilei Zhang,Zongjiu Jiao,Jiaojie Song,Ling Li,Xinxiao Lu,Linyu Yuan,Kaiqi Liu,Xingli Zhao,Yingchang Mi
中文翻译：
维奈托克联合三天多频地西他滨 （DEC3-VEN） 治疗不适合的老年或强化化疗的新诊断急性髓性白血病患者。
京公网安备 11010802027423号